Rafferty Asset Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Sell
27,249
-8,061
-23% -$434K 0.01% 667
2025
Q4
$1.71M Buy
35,310
+5,225
+17% +$204K 0.01% 686
2025
Q3
$921K Buy
30,085
+3,256
+12% +$74.7K ﹤0.01% 812
2025
Q2
$596K Sell
26,829
-4,351
-14% -$91.1K ﹤0.01% 851
2025
Q1
$580K Sell
31,180
-39,703
-56% -$662K ﹤0.01% 837
2024
Q4
$938K Buy
70,883
+32,185
+83% +$780K ﹤0.01% 806
2024
Q3
$1.3M Sell
38,698
-10,973
-22% -$375K ﹤0.01% 740
2024
Q2
$1.24M Sell
49,671
-41,023
-45% -$955K ﹤0.01% 763
2024
Q1
$2.04M Buy
+90,694
New +$2.15M 0.01% 680
2023
Q4
Sell
-62,336
Closed -$1.12M 1074
2023
Q3
$1.12M Sell
62,336
-30,314
-33% -$578K 0.01% 766
2023
Q2
$1.88M Buy
92,650
+15,316
+20% +$311K 0.01% 670
2023
Q1
$1.68M Buy
77,334
+7,040
+10% +$171K 0.01% 660
2022
Q4
$2.18M Sell
70,294
-7,366
-9% -$208K 0.02% 545
2022
Q3
$1.98M Buy
77,660
+38,633
+99% +$906K 0.02% 509
2022
Q2
$792K Sell
39,027
-7,565
-16% -$168K 0.01% 714
2022
Q1
$1.15M Buy
46,592
+3,230
+7% +$97.8K 0.01% 747
2021
Q4
$1.51M Buy
43,362
+13,195
+44% +$418K 0.01% 756
2021
Q3
$818K Sell
30,167
-17,796
-37% -$452K 0.01% 917
2021
Q2
$1.24M Sell
47,963
-42,840
-47% -$1.03M 0.01% 808
2021
Q1
$1.96M Buy
90,803
+79,203
+683% +$2M 0.01% 636
2020
Q4
$249K Sell
11,600
-17,835
-61% -$433K ﹤0.01% 911
2020
Q3
$434K Buy
29,435
+12,507
+74% +$226K 0.01% 728
2020
Q2
$378K Buy
+16,928
New +$309K 0.01% 777
2020
Q1
Sell
-76,304
Closed -$1.24M 607
2019
Q4
$1.24M Buy
76,304
+16,661
+28% +$394K 0.02% 496
2019
Q3
$2.09M Buy
59,643
+19,948
+50% +$949K 0.03% 366
2019
Q2
$2.24M Sell
39,695
-3,482
-8% -$251K 0.04% 376
2019
Q1
$3.15M Buy
+43,177
New +$2.98M 0.05% 213

Other funds holding ANAB